Comparative Marker Assessment in Small Cell Lung Cancer with Good and Poor Prognosis

被引：0
|
作者：
Schmidt, L. [1 ]
Specht, E. [1 ]
Reimann, C. [1 ]
Kaemmerer, D. [2 ]
Wirtz, R. M. [3 ]
Saenger, J. [4 ]
Schulz, S. [1 ]
Lupp, A. [1 ]
机构：
[1] Jena Univ Hosp, Dept Pharmacol & Toxicol, Jena, Germany
[2] Zent Klin Bad Berka, Dept Gen & Visceral Surg, Bad Berka, Germany
[3] Stratifyer Mol Pathol, Cologne, Germany
[4] Lab Pathol & Cytol, Bad Berka, Germany
来源：
NEUROENDOCRINOLOGY | 2015年 / 102卷 / 1-2期
关键词：
sclc; sstr; cxcr4; proliferation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E11
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [1] Elevated Serum Level of Angiopoietin-2 as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer
    Zhang, Cai-Lian
    Ge, Sheng-Li
    Yang, Ning
    Zhang, Jin-Ran
    Tian, Dong-Dong
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 236 (04): : 305 - 309
  • [2] CADM1 is a serum marker for small-cell lung cancer associated with poor prognosis and metastasis
    Ito, Takeshi
    Funaki, Toko
    Iwanari, Hiroko
    Tanaka, Goh
    Nagase, Takahide
    Hamakubo, Takao
    Murakami, Yoshinori
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [3] Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
    Khuri, FR
    Wu, H
    Lee, JJ
    Kemp, BL
    Lotan, R
    Lippman, SM
    Feng, L
    Hong, WK
    Xu, XC
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (04) : 861 - 867
  • [4] TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer
    Zhou, Fang
    Wang, Meng
    Aibaidula, Mijiti
    Zhang, Zhiguo
    Aihemaiti, Abudusaimaiti
    Aili, Rezhake
    Chen, Hao
    Dong, Shuangfeng
    Wei, Wei
    Maimaitiaili, Abulizi
    [J]. MEDICAL SCIENCE MONITOR, 2020, 26
  • [5] LINE-1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer
    Saito, Kenichiro
    Kawakami, Kazuyuki
    Matsumoto, Isao
    Oda, Makoto
    Watanabe, Go
    Minamoto, Toshinari
    [J]. CANCER RESEARCH, 2010, 70
  • [6] CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer
    Sakabe, Tomohiko
    Azumi, Junya
    Haruki, Tomohiro
    Umekita, Yoshihisa
    Nakamura, Hiroshige
    Shiota, Goshi
    [J]. ONCOLOGY LETTERS, 2017, 13 (05) : 3703 - 3708
  • [7] Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
    Shun-Dong Dai
    Yan Wang
    Yuan Miao
    Yue Zhao
    Yong Zhang
    Gui-Yang Jiang
    Peng-Xin Zhang
    Zhi-Qiang Yang
    En-Hua Wang
    [J]. BMC Cancer, 9
  • [8] Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
    Hong, Ling-Zhi
    Wei, Xiao-Wei
    Chen, Jin-Fei
    Shi, Yi
    [J]. ONCOLOGY LETTERS, 2013, 6 (06) : 1595 - 1603
  • [9] Activin A is Associated with Poor Prognosis and Promotes Metastatic Growth in Small Cell Lung Cancer
    Rozsas, Anita
    Lang, Elisabeth
    Hoda, Mir
    Klikovits, Thomas
    Kovacs, Ildiko
    Torok, Szilvia
    Hegedus, Balazs
    Berger, Walter
    Klepetko, Walter
    Grusch, Michael
    Dome, Balazs
    Laszlo, Viktoria
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S712 - S712
  • [10] High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer
    Wang, Xiaoyan
    Lin, Lijuan
    Ren, Xiangshan
    Lin, Zhenhua
    Li, Zhuhu
    Li, Chunyu
    Jin, Tiefeng
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (08): : 5016 - 5023
12345